Back
Recursion Pharmaceuticals Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
44
RXRX
Recursion Pharmaceuticals
Last Price:
6.81
Seasonality Move:
-13.67%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- The current trend is relatively stagnant and RXRX is experiencing slight buying pressure.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.7 | Buy |
| 20-day SMA: | 6.78 | Buy |
| 50-day SMA: | 7.17 | Sell |
| 200-day SMA: | 9.05 | Sell |
| 8-day EMA: | 6.73 | Buy |
| 20-day EMA: | 6.75 | Buy |
| 50-day EMA: | 7.14 | Sell |
| 200-day EMA: | 8.27 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 49.62 | Sell |
| Chaikin Money Flow: | 325985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.3 - 7.44) | Sell |
| Bollinger Bands (100): | (6.84 - 9.02) | Sell |
Recursion Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 6.81 while RXRX 8-day simple moving average is 6.70, which is a Buy signal.
- The stock price of RXRX is 6.81 while Recursion Pharmaceuticals 20-day SMA is 6.78, which makes it a Buy.
- Recursion Pharmaceuticals 50-day simple moving average is 7.17 while RXRX share price is 6.81, making it a Sell technically.
- RXRX stock price is 6.81 and Recursion Pharmaceuticals 200-day simple moving average is 9.05, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Sell
44
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a Sell
The current Recursion Pharmaceuticals [RXRX] share price is $6.81. The Score for RXRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
1.92B
Price in USD:
6.81
Share Volume:
7.48M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
15.74
52-Week Low:
4.97
Sell
44
Recursion Pharmaceuticals (RXRX)
is a Sell
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?
The Recursion Pharmaceuticals stock price is 6.81 USD today. -
Will RXRX stock go up or go down?
Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Recursion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 6.81 while RXRX 8-day exponential moving average is 6.73, which is a Buy signal.
- The stock price of RXRX is 6.81 while Recursion Pharmaceuticals 20-day EMA is 6.75, which makes it a Buy.
- Recursion Pharmaceuticals 50-day exponential moving average is 7.14 while RXRX share price is 6.81, making it a Sell technically.
- RXRX stock price is 6.81 and Recursion Pharmaceuticals 200-day simple moving average is 8.27, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.09 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
- RXRX Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Recursion Pharmaceuticals is a Sell
- Recursion Pharmaceuticals Relative Strength Index (RSI) is 49.62, which suggest Recursion Pharmaceuticals is oversold
- The Bollinger Bands (25) for Recursion Pharmaceuticals is (6.3 - 7.44), which suggest Recursion Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Recursion Pharmaceuticals is (6.84 - 9.02), which suggest Recursion Pharmaceuticals is a Sell
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.